443 related articles for article (PubMed ID: 20699015)
1. Experimental approaches for the generation of induced pluripotent stem cells.
Sommer CA; Mostoslavsky G
Stem Cell Res Ther; 2010 Aug; 1(3):26. PubMed ID: 20699015
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
3. Generation of Induced Pluripotent Stem Cells with Substitutes for Yamanaka's Four Transcription Factors.
Xiao X; Li N; Zhang D; Yang B; Guo H; Li Y
Cell Reprogram; 2016 Oct; 18(5):281-297. PubMed ID: 27696909
[TBL] [Abstract][Full Text] [Related]
4. Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.
Rony IK; Baten A; Bloomfield JA; Islam ME; Billah MM; Islam KD
Cell Prolif; 2015 Apr; 48(2):140-56. PubMed ID: 25643745
[TBL] [Abstract][Full Text] [Related]
5. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors.
Ye L; Muench MO; Fusaki N; Beyer AI; Wang J; Qi Z; Yu J; Kan YW
Stem Cells Transl Med; 2013 Aug; 2(8):558-66. PubMed ID: 23847002
[TBL] [Abstract][Full Text] [Related]
6. Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells.
Hu C; Li L
Regen Med; 2016 Jan; 11(1):105-32. PubMed ID: 26679838
[TBL] [Abstract][Full Text] [Related]
7. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
8. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
Febbraro F; Chen M; Denham M
Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
[TBL] [Abstract][Full Text] [Related]
9. Reprogramming Human Fibroblasts to Induced Pluripotent Stem Cells Using the GFP-Marked Lentiviral Vectors in the Chemically Defined Medium.
Shao Z; Cevallos RR; Hu K
Methods Mol Biol; 2021; 2239():101-116. PubMed ID: 33226615
[TBL] [Abstract][Full Text] [Related]
10. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
Heng BC; Fussenegger M
Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
[TBL] [Abstract][Full Text] [Related]
11. Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications.
Liu G; David BT; Trawczynski M; Fessler RG
Stem Cell Rev Rep; 2020 Feb; 16(1):3-32. PubMed ID: 31760627
[TBL] [Abstract][Full Text] [Related]
12. Overcoming barriers to the clinical utilization of iPSCs: reprogramming efficiency, safety and quality.
Cao S; Loh K; Pei Y; Zhang W; Han J
Protein Cell; 2012 Nov; 3(11):834-45. PubMed ID: 23073833
[TBL] [Abstract][Full Text] [Related]
13. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
Ye H; Wang Q
Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
[TBL] [Abstract][Full Text] [Related]
14. Excision of viral reprogramming cassettes by Cre protein transduction enables rapid, robust and efficient derivation of transgene-free human induced pluripotent stem cells.
Kadari A; Lu M; Li M; Sekaran T; Thummer RP; Guyette N; Chu V; Edenhofer F
Stem Cell Res Ther; 2014 Apr; 5(2):47. PubMed ID: 24713299
[TBL] [Abstract][Full Text] [Related]
15. Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications.
Yoshihara M; Hayashizaki Y; Murakawa Y
Stem Cell Rev Rep; 2017 Feb; 13(1):7-16. PubMed ID: 27592701
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications.
Cerneckis J; Cai H; Shi Y
Signal Transduct Target Ther; 2024 Apr; 9(1):112. PubMed ID: 38670977
[TBL] [Abstract][Full Text] [Related]
17. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
18. An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells.
Haridhasapavalan KK; Borgohain MP; Dey C; Saha B; Narayan G; Kumar S; Thummer RP
Gene; 2019 Feb; 686():146-159. PubMed ID: 30472380
[TBL] [Abstract][Full Text] [Related]
19. Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy.
Panda A; Gurusamy N; Rajasingh S; Carter HK; Thomas EL; Rajasingh J
Differentiation; 2020; 112():58-66. PubMed ID: 31954271
[TBL] [Abstract][Full Text] [Related]
20. Application of Modified mRNA in Somatic Reprogramming to Pluripotency and Directed Conversion of Cell Fate.
Wang AYL
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
